167 related articles for article (PubMed ID: 20589701)
1. Acquired factor VIII inhibitor in Sjögren's syndrome.
Vintimilla M; Joseph A; Ranganathan P
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1047-50. PubMed ID: 20589701
[No Abstract] [Full Text] [Related]
2. Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome.
Ciccia F; Giardina A; Rizzo A; Guggino G; Cipriani P; Carubbi F; Giacomelli R; Triolo G
Ann Rheum Dis; 2013 May; 72(5):782-3. PubMed ID: 23264342
[No Abstract] [Full Text] [Related]
3. Complete remission of protein-losing gastroenteropathy associated with Sjögren's syndrome by B cell-targeted therapy with rituximab.
Uraoka Y; Tanigawa T; Watanabe K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Arakawa T
Am J Gastroenterol; 2012 Aug; 107(8):1266-8. PubMed ID: 22859008
[No Abstract] [Full Text] [Related]
4. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
Nikiphorou E; Hall FC
Rheumatology (Oxford); 2014 Oct; 53(10):1906-7. PubMed ID: 24729401
[No Abstract] [Full Text] [Related]
5. [B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?].
Atzeni F; Sarzi-Puttini P
Reumatismo; 2010; 62(2):87-8. PubMed ID: 20657883
[No Abstract] [Full Text] [Related]
6. Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome.
Sánchez-Cano D; Callejas-Rubio JL; Lara-Jiménez MA; López-Trascasa M; Circadi M; Ortego-Centeno N
Lupus; 2008 Mar; 17(3):228-9. PubMed ID: 18372365
[No Abstract] [Full Text] [Related]
7. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
[No Abstract] [Full Text] [Related]
8. Latest update on the primary Sjögren's syndrome.
Youinou P; Pers JO
Presse Med; 2012 Sep; 41(9 Pt 2):e437-9. PubMed ID: 22857888
[No Abstract] [Full Text] [Related]
9. Sjogren's syndrome. When your tissues dry out.
Mayo Clin Health Lett; 2006 Jul; 24(7):7. PubMed ID: 16865802
[No Abstract] [Full Text] [Related]
10. Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.
Somer BG; Tsai DE; Downs L; Weinstein B; Schuster SJ;
Arthritis Rheum; 2003 Jun; 49(3):394-8. PubMed ID: 12794796
[No Abstract] [Full Text] [Related]
11. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
12. Sjogren's syndrome and pseudolymphoma.
Deutsch HJ
Ann Otol Rhinol Laryngol; 1967 Dec; 76(5):1074-84. PubMed ID: 6074240
[No Abstract] [Full Text] [Related]
13. Progress and regression within primary Sjögren's syndrome.
Manthorpe R; Bredberg A; Henriksson G; Larsson A
Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
[TBL] [Abstract][Full Text] [Related]
14. Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome.
Pollard RP; Abdulahad WH; Bootsma H; Meiners PM; Spijkervet FK; Huitema MG; Burgerhof JG; Vissink A; Kroese FG
Ann Rheum Dis; 2013 Dec; 72(12):2048-50. PubMed ID: 23864239
[No Abstract] [Full Text] [Related]
15. Successful treatment of refractory neuroSjogren with Rituximab.
Yamout B; El-Hajj T; Barada W; Uthman I
Lupus; 2007; 16(7):521-3. PubMed ID: 17670852
[TBL] [Abstract][Full Text] [Related]
16. [Case of retroperitoneal fibrosis exhibiting a variety of auto- antibodies and complicated by Sjogren's syndrome].
Sakamoto K; Ueda K; Kawabata T; Harada N; Kida Y; Nibu T; Furuie D; Haneda K; Yoshikawa R
Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2319-21. PubMed ID: 9921220
[No Abstract] [Full Text] [Related]
17. [Is rituximab a promising treatment for Sjögren's syndrome?].
Devauchelle-Pensec V; Pers JO; Youinou P; Saraux A
Rev Med Interne; 2008 Dec; 29(12):967-70. PubMed ID: 18403066
[No Abstract] [Full Text] [Related]
18. Interferon alfa treatment for Sjogren's syndrome associated neuropathy.
Yamada S; Mori K; Matsuo K; Inukai A; Kawagashira Y; Sobue G
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):576-8. PubMed ID: 15774450
[TBL] [Abstract][Full Text] [Related]
19. [First experience with the application of rituximab for the treatment of patients with Sjogren's syndrome and disease].
Vasil'ev VI; Logvinenko OA; Kokosadze NV; Gaĭduk IV; Varlamova EIu; Kovrigina AM; Gorodetskiĭ VR; Nasonov EL
Vestn Ross Akad Med Nauk; 2009; (2):3-10. PubMed ID: 19283903
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy.
Dannhäuser D; Casonato A; Pietrogrande F; Pontara E; Bertomoro A; Zerbinati P; Girolami A
Acta Haematol; 1994; 91(2):73-6. PubMed ID: 8023647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
